
Karim Boudadi, MD
Sarcoma and Connective Tissue Medical Oncology
Hematologic Coagulation Disorders
Anemia and Bone Marrow Disorders
Benign Hematology
Head and Neck Medical Oncology
Hematology Oncology
Medical Oncology
- Johns Hopkins School of Medicine Faculty
4.7 of 5 stars
84 Ratings, 27 ReviewsLanguages
- Spanish
- French
- English
14 Insurances Accepted
View allGender
MaleAbout Karim Boudadi
Primary Academic Title
Assistant Professor of Oncology
Background
Karim Boudadi, M.D., is a medical oncologist and hematologist with the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital in Washington, D.C., and an assistant professor in the Department of Oncology at Johns Hopkins University School of Medicine.
Listen to Dr. Boudadi’s Cancer Matters podcast episode to learn more about his work.
Dr. Boudadi has expertise in treating cancers of the head and neck, including salivary gland cancers, as well as cancers of the esophagus, and bone and soft tissue sarcomas. Having completed dual training in medical oncology and hematology at Johns Hopkins University, Dr. Boudadi also treats patients with benign hematologic conditions or non-cancer related blood disorders, such as anemia, low blood counts, bleeding disorders, and clotting disorders.
Dr. Boudadi earned his medical degree from the University of Rochester School of Medicine. He completed a residency in internal medicine at the University of Michigan in Ann Arbor, MI, and went on to serve as a clinical lecturer in the Department of Internal Medicine at the University of Michigan Medical School before joining Johns Hopkins. He then completed dual fellowship training in both hematology and medical oncology at the Johns Hopkins University School of Medicine. Dr. Boudadi's research during his fellowship focused on prostate cancer and immunotherapy.
Dr. Boudadi is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, and the American Medical Association. He is also a member of the Hematology and Oncology Fellowship Selection Committee at The Johns Hopkins University School of Medicine.
Dr. Boudadi has extensive clinical trial development experience and has published his work in peer-reviewed journals. His primary research interest is immunotherapy.
Recent News Articles and Media Coverage
Cancer Matters Podcast: Dr. Bill Nelson discussing the treatment of HPV related head and neck cancers, Johns Hopkins Kimmel Cancer Center Podcasts (May 23, 2019)
Research Interests
Immunotherapy
Selected Publications
Boudadi K, Suzman D, Anagnostou V, Fu W, Luber B, Wang H, Niknafs N, White J, Silberstein J, Sullivan R, Dowling D, Harb R, Nirschl T, Veeneman B, Tomlins S, Wang Y, Jendrisak A, Graf R, Dittamore R, Carducci M, Eisenberger M, Haffner M, Meeker A, Eshleman J, Luo J, Velculescu VE, Drake C, Antonarakis E. Ipilimumab plus Nivolumab and DNA-Repair Defects in AR-V7-Expressing Metastatic Prostate Cancer. Oncotarget. 2018 Jun 19;9(47):28561-28571
Boudadi K. Adjuvant Chemotherapy and Novel Therapeutics. Fakhry/Pazoki/Kiess/Eisele, Oral Cancer: Evaluation, Therapy, and Rehabilitation. Thieme USA. 2021
Cheung LS, Chen L, Oke TF, Schaffer TB, Boudadi K, Ngo JT, Gross JM, Kemberling H, Diaz LA, Lipson E, Sidhom JW, Taube J, Anders R, Pardoll DM, Le DT, Meyer CF, Llosa N. Anti-PD-1 elicits regression of undifferentiated pleomorphic sarcomas with UV-mutation signatures. J Immunother Cancer. 2021 Jun;9(6):e002345. doi: 10.1136/jitc-2021-002345. PMID: 34103354
Park JC, Durbeck J, Boudadi K, Ho WJ, Kang H. The efficacy of anti-PD-1 immune checkpoint inhibitor in nasopharyngeal carcinoma. Oral Oncol. 2020 Sep;108:104935. doi: 10.1016/j.oraloncology.2020.104935. Epub 2020 Aug 10
Shenderov E, Boudadi K, Fu W, Wang H, Sullivan R, Jordan A, Dowling D, Harb R, Schonhoft J, Jendrisak A, Carducci MA, Eisenberger MA, Eshleman JR, Luo J, Drake CG, Pardoll DM, Antonarakis ES. Nivolumab plus ipilimumab, with or without enzalutamide, in AR-V7-expressing metastatic castration-resistant prostate cancer: A phase-2 nonrandomized clinical trial. Prostate. Prostate. 2021 May;81(6):326-338. doi: 10.1002/pros.24110. Epub 2021 Feb 26.
Honors
- 2024 Johns Hopkins Medicine Clinical Award for Excellence in Service and Professionalism
- 2024 Washingtonian Magazine Top Doctors – Oncology/Hematology
Memberships
- American Medical Association,
Member
- American College of Physicians,
Associate Member
- American Society of Clinical Oncology,
Member
- American Society of Hematology,
Member
Locations
- Sibley Memorial Hospital
- 5255 Loughboro Road Northwest, Building B, Washington, DC 20016
- phone: 202-660-6500
- fax: 202-660-6501
- Johns Hopkins Health Care & Surgery Center — Bethesda
- 6420 Rockledge Drive, Suite 4950, Bethesda, MD 20817
- phone: 443-997-6467
- fax: 301-530-2650
Expertise
Education
Johns Hopkins University School of Medicine
Fellowship, Hematology and Oncology, 2017University of Michigan Medicine
Residency, Internal Medicine, 2013University of Rochester School of Medicine and Dentistry
Medical Education, MD, 2010Board Certifications
Medical Oncology
American Board of Internal Medicine, 2017Hematology
American Board of Internal Medicine, 2017Internal Medicine
American Board of Internal Medicine, 2013Insurance
- Aetna
- CareFirst
- Cigna
- First Health
- Geisinger Health Plan
- HealthSmart/Accel
- Humana
- Johns Hopkins Health Plans
- MultiPlan
- Pennsylvania's Preferred Health Networks (PPHN)
- Point Comfort Underwriters
- Private Healthcare Systems (PHCS)
- UnitedHealthcare
- Veteran Affairs Community Care Network (Optum-VACCN)
Ratings & Reviews
4.7 out of 5
84 ratings, 27 reviewsThe Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
- 5 out of 5 starsReviewed on 11/12/2024
General medical oncologist. I have precursor to blood cancer, not his specialty area.
- 5 out of 5 starsReviewed on 11/7/2024
I only spoke to this provider for a very short time. My visit lasted less than 20 minutes, so my responses have to be given some contest. Dr. Boudadi was professional and knowledgeable.
- 5 out of 5 starsReviewed on 11/7/2024
John Hopkins is the best in healthcare. They make treatment very easy.
- 4 out of 5 starsReviewed on 10/30/2024
Knowledgeable and courteous
- 5 out of 5 starsReviewed on 10/23/2024
Dr Boudadi was very professional and efficient. He explained that the cancer was gone and how we would move to every three months appointment to ensure does not come back
- 5 out of 5 starsReviewed on 10/23/2024
I was pleased to meet him and will be pleased to see him again
- 5 out of 5 starsReviewed on 10/16/2024
Dr. Boudadi did a great job; I appreciate the time he took to understand my problem and explain the options.
- 5 out of 5 starsReviewed on 10/16/2024
Great urgency and follow thru
- 5 out of 5 starsReviewed on 9/26/2024
Dr. Boudadi was able to out me at ease even though something might be seriously wrong. I am really glad he is part of my health care team.
- 5 out of 5 starsReviewed on 9/17/2024
Excellent
- 5 out of 5 starsReviewed on 9/17/2024
Dr Boudadi is the right doctor for me
- 5 out of 5 starsReviewed on 8/27/2024
He is very good and knowledgeable, caring and friendly
- 5 out of 5 starsReviewed on 8/27/2024
Excellent care.
- 5 out of 5 starsReviewed on 8/22/2024
Provider is very good. No issues.
- 5 out of 5 starsReviewed on 7/23/2024
I appreciated that he was concerned about treating the individual and not just looking at numbers. He seemed knowledgeable and practical.
- 5 out of 5 starsReviewed on 7/17/2024
Dr. Boudadi was so kind and caring through my treatment. He is very knowledgeable and offers reassurance
- 5 out of 5 starsReviewed on 6/10/2024
My first meeting with Dr. Boudadi was informative and helpful. Now diagnosed with cancer, there is a lot to learn and this mtg was a very good start.
- 5 out of 5 starsReviewed on 6/6/2024
Very knowledgeable, personable, and caring
- 5 out of 5 starsReviewed on 5/22/2024
Dr Boudadi is a wonderful doctor, both effective and empathetic. I am happy to be in his care.
- 5 out of 5 starsReviewed on 5/22/2024
This was my first meeting with a hematologist and my first visit with Dr Boudadi. It could not have been more informative to me about a medical subject that I knew nothing about. When I left I knew what my problem was and the procedure we were undertaking. Excellent!
- 5 out of 5 starsReviewed on 5/14/2024
I like Dr. Boudadi and have appreciated his care and efforts to explain my condition to me.
- 5 out of 5 starsReviewed on 5/7/2024
I felt had a good experience with Dr. Boudadi
- 5 out of 5 starsReviewed on 4/16/2024
He is a great doctor
- 5 out of 5 starsReviewed on 3/21/2024
Excellent doctor
- 5 out of 5 starsReviewed on 3/20/2024
Dr. Boudadi and his team were very professional, knowledgeable and highly skilled to address my issues.
- 4 out of 5 starsReviewed on 3/14/2024
Excellent provider, knowledgeable and courteous
- 5 out of 5 starsReviewed on 3/6/2024
Very competent.